Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Treatment
Sort By
Newest First
1 / 3
Nektar Therapeutics
NKTR-255
Nektar Presents Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia
Nektar Therapeutics
PR-10-24-NI-85
Nov 08, 2024
Children's Hospital of Philadelphia
Clinical Development
Children's Hospital of Philadelphia Researchers Find Promising New Immunotherapy Target in Neuroblastoma and Other Cancers
Children's Hospital of Philadelphia
PR-10-24-NI-60
Oct 25, 2024
Orasis Pharmaceuticals
Announcement
Orasis Pharmaceuticals Announces Licensing Agreement with Optus Pharmaceuticals for Commercialization of Qlosi™ 0.4% in Korea
Orasis Pharmaceuticals
PR-10-24-NI-49
Oct 17, 2024
Soligenix, Inc.
Clinical Trials
HyBryte™ expanded treatment results to be presented at the European Organisation for research and treatment of cancer conference
Soligenix, Inc.
PR-10-24-NI-33
Oct 07, 2024
BRISTOL MYERS SQUIBB FOUNDATION
Clinical Trials
The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials
BRISTOL MYERS SQUIBB FOUNDATION
PR-M11-20-015-1188
Nov 18, 2020
Bellerophon
FDA
FDA Grants Bellerophon Emergency Expanded Access for INOpulse® for the Treatment of COVID-19 Virus
Bellerophon
PR-M03-20-NI-032
Mar 20, 2020
Averitas Pharma, Inc.
FDA Acceptance
Averitas Pharma Announces FDA Acceptance for Neuropathic Pain Treatment
Averitas Pharma, Inc.
PR-M12-19-NI-032
Dec 20, 2019
CRISPR
Startup Navega Therapeutics Aims to Develop a CRISPR Treatment for Pain
Emilie Branch
Pharma's Almanac
PAO-M09-19-NI-008
Sep 04, 2019
CRISPR
Using CRISPR to Treat Muscular Dystrophy
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-021
Aug 15, 2019
Roche
Oncology
Roche Receives CHMP Positive Opinion for New Tecentriq-based Combination Therapy as an Initial Treatment for Most Common Form of Advanced Lung Cancer
Roche
PR-M08-19-NI-004
Aug 01, 2019
Oncology
New Approach to Treating Pancreatic Cancer Being Explored
Nice Insight
PAO-M07-19-NI-023
Jul 30, 2019
Research
New Treatment Approach for Pancreatic Cancer
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-023-2345
Jul 22, 2019
U.S. Food & Drug Administration
Drug Approval
FDA Expands Approval of Treatment for Cystic Fibrosis to Include Patients Ages 6 and Older
U.S. Food & Drug Administration
PR-M06-19-NI-056
Jun 27, 2019
Daiichi-Sankyo
FDA Review
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Daiichi-Sankyo
PR-M06-19-NI-045
Jun 26, 2019
U.S. Food & Drug Administration
FDA Approval
FDA Approves New Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women
U.S. Food & Drug Administration
PR-M06-19-NI-044
Jun 25, 2019
Drug Delivery
Drug Delivery Tech Based on Sea Lamprey Immune System Could Facilitate Treatment of Brain Disorders
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-030
May 29, 2019
Amgen
Drug Development
EVENITY™ (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture
Amgen
PR-M04-19-NI-054
Apr 17, 2019
Opioid Treatment
Failed Depression Drug Could be Opioid Addiction Treatment
Emilie Branch
Pharma's Almanac
PAO-M04-19-NI-012
Apr 10, 2019
Cellectis
Allogeneic CAR-T
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
Cellectis
PR-M04-19-NI-028
Apr 09, 2019
Drug Development
Promising Treatment for Brain Cancer
Pharma's Almanac
PAO-M02-19-NI-019
Feb 21, 2019
1 / 3
